FDA inspection
Daewoo Pharmaceutical Co., Ltd.: FDA inspection ending Mar 28, 2017
FDA inspection 1009230 · Voluntary Action Indicated (VAI) · Saha
Key facts
| Inspection ID | 1009230 |
|---|---|
| Firm | Daewoo Pharmaceutical Co., Ltd. |
| FEI number | 1000448124 |
| Address | 153 Dadae-Ro |
| City | Saha |
| Country | Korea (the Republic of) |
| Fiscal year | 2017 |
| Inspection end date | Mar 28, 2017 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data